loading

Aspira Womens Health Inc (AWH) 最新ニュース

pulisher
Jan 12, 2025

Bioxytran (OTCMKTS:BIXT) to Release Cancer Preprint Revealing Potential Immunotherapy EnhancementOn January 10, 2025, Bioxytran Inc., a clinical-stage biotechnology company focused on developing oral and intravenous drugs for various conditions, a - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

Aspira Women’s Health (NASDAQ:AWH) Now Covered by Analysts at StockNews.com - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

Aspira Women’s Health Appoints Mike Buhle as SVP of Commercial Operations - citybiz

Jan 10, 2025
pulisher
Jan 10, 2025

Aspira Women's Health Inc. Appoints Mike Buhle as SVP of Commercial Operations - Marketscreener.com

Jan 10, 2025
pulisher
Jan 10, 2025

Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations - AccessWire

Jan 10, 2025
pulisher
Jan 07, 2025

Aspira Women's Health CFO resigns, CEO assumes duties - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

Aspira Women’s Health CFO Resignation and Leadership Update - TipRanks

Jan 07, 2025
pulisher
Jan 06, 2025

AWH Stock Surges Over 5% Amid Mixed Analyst Ratings - GuruFocus.com

Jan 06, 2025
pulisher
Dec 31, 2024

Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com - Defense World

Dec 31, 2024
pulisher
Dec 27, 2024

Aspira Women's Health in Shelton to use $10M grant to create blood test to detect endometriosis - CTPost

Dec 27, 2024
pulisher
Dec 25, 2024

Aspira Women’s Health (NASDAQ:AWH) Earns Hold Rating from Analysts at StockNews.com - Defense World

Dec 25, 2024
pulisher
Dec 25, 2024

Organon & Co. (NYSE: OGN) Reduces Board Size Following Resignation of Director - Defense World

Dec 25, 2024
pulisher
Dec 18, 2024

Aspira Women's Health's SWOT analysis: stock outlook amid diagnostic growth - Investing.com India

Dec 18, 2024
pulisher
Dec 17, 2024

Aspira Women's Health CEO steps down, interim appointed By Investing.com - Investing.com Canada

Dec 17, 2024
pulisher
Dec 16, 2024

Aspira Women’s Health CEO Transition and Leadership Change - TipRanks

Dec 16, 2024
pulisher
Dec 16, 2024

AWHAspira Women's Health Inc. Latest Stock News & Market Updates - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer - citybiz

Dec 16, 2024
pulisher
Dec 16, 2024

Aspira Women’s Health Appoints Dr. Sandra Milligan as Interim CEO - citybiz

Dec 16, 2024
pulisher
Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO - The Manila Times

Dec 16, 2024
pulisher
Dec 16, 2024

Aspira Women's Health CEO Steps Down Following OvaWatch Launch, $10M Research Grant Success - StockTitan

Dec 16, 2024
pulisher
Dec 13, 2024

StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World

Dec 13, 2024
pulisher
Dec 11, 2024

Aspira Women's Health's SWOT analysis: stock faces growth potential amid financial hurdles - Investing.com Nigeria

Dec 11, 2024
pulisher
Dec 05, 2024

CURE® SURVEY UNVEILS WHAT INVESTORS LOOK FOR IN FUNDING WOMEN'S HEALTH - PR Newswire

Dec 05, 2024
pulisher
Dec 03, 2024

AWS supports ARPA-H Sprint for Women’s Health to advance crucial research and solutions - AWS Blog

Dec 03, 2024
pulisher
Dec 03, 2024

Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award - The Manila Times

Dec 03, 2024
pulisher
Dec 03, 2024

Aspira Women's Health Secures $2M ARPA-H Grant for AI-Powered Endometriosis Test - StockTitan

Dec 03, 2024
pulisher
Dec 01, 2024

StockNews.com Initiates Coverage on Aspira Women’s Health (NASDAQ:AWH) - Defense World

Dec 01, 2024
pulisher
Nov 20, 2024

Aspira: Q3 Earnings Snapshot - New Haven Register

Nov 20, 2024
pulisher
Nov 19, 2024

Aspira Women's Health Inc. (AWH) reports earnings - Quartzy

Nov 19, 2024
pulisher
Nov 19, 2024

Aspira Women's Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 19, 2024
pulisher
Nov 15, 2024

Aspira Women’s Health Inc. (NASDAQ:AWH) Q3 2024 Earnings Call Transcript - MSN

Nov 15, 2024
pulisher
Nov 15, 2024

Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ... By GuruFocus - Investing.com Canada

Nov 15, 2024
pulisher
Nov 14, 2024

Aspira Women’s Health Reports Q3 2024 Growth and Strategic Advances - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Expands Stake in Aspira Womens Health Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Aspira Women’s Health reports Q3 revenue $2.3M, consensus $2.73M - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Aspira Women's Health Q3: OvaWatch Grows 27%, Secures $10M Federal Contract | AWH Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 13, 2024
pulisher
Nov 09, 2024

Aspira Women?s Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch - Marketscreener.com

Nov 09, 2024
pulisher
Nov 07, 2024

Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch® - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Aspira Women's Health Expands BioReference Partnership, Reaches 15M+ Women With OvaWatch | AWH Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

FDA's LDT RULE: Steps to Prepare for Your FDA 1st Milestone SubmissionDARKDaily.com - DARKDaily.com - Laboratory News

Nov 07, 2024
diagnostics_research LH
$237.20
price up icon 0.97%
$172.57
price up icon 4.12%
$139.32
price up icon 2.47%
diagnostics_research WAT
$409.32
price up icon 1.07%
diagnostics_research MTD
$1,306.00
price up icon 2.60%
$428.76
price up icon 2.42%
大文字化:     |  ボリューム (24 時間):